Delivery Order SPE2DB22D9367-SPE2DB24FSX80

Award Date 5/8/24

Potential Completion Date 5/30/24

Potential Value $119K

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $119,384.20 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, which is a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This contract allows the DLA to place orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The award is for the delivery of GIVLAARI 189 MG/ML VIALML, and there is no set-aside designation. DMS Pharmaceutical Group is the prime contractor and handles direct distribution of prescription drugs and pharmacy services to Department of Defense sites through this and other prime vendor contracts.

Generated 8/7/24, 9:33 AM